Joachim Mittendorf

2.1k citations

29 papers · 1.4k indexed · h-index 18

Molecular Biology
Organic Chemistry top 5%
Pulmonary and Respiratory Medicine top 10%
Cardiology and Cardiovascular Medicine top 5%
Physiology top 10%

Co-authors: Michael G. Hahn Alexander Kühl Hartmut Schirok Johannes‐Peter Stasch Karl‐Heinz Schlemmer Miljenko Dumić Alexander Straub K. Peter C. Vollhardt
Topics: Chemical Synthesis and Analysis (7 papers)Nitric Oxide and Endothelin Effects (7 papers)Pulmonary Hypertension Research and Treatments (5 papers)
Cited by: Organic Chemistry Cardiology and Cardiovascular Medicine Toxicology
Journals: Angewandte Chemie International Edition Journal of Medicinal Chemistry Antimicrobial Agents and Chemotherapy
Partner nations: Germany United States Croatia

In The Last Decade

Joachim Mittendorf

29 papers receiving 1.4k citations

Peers

Countries citing papers authored by Joachim Mittendorf

Since Specialization

Citations

This map shows the geographic impact of Joachim Mittendorf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joachim Mittendorf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joachim Mittendorf more than expected).

Fields of papers citing papers by Joachim Mittendorf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joachim Mittendorf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joachim Mittendorf. The network helps show where Joachim Mittendorf may publish in the future.

Co-authorship network of co-authors of Joachim Mittendorf

This figure shows the co-authorship network connecting the top 25 collaborators of Joachim Mittendorf. A scholar is included among the top collaborators of Joachim Mittendorf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joachim Mittendorf. Joachim Mittendorf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery and Preclinical Characterization of Fulacimstat (BAY 1142524), a Potent and Selective Chymase Inhibitor As a New Profibrinolytic Approach for Safe Thrombus Resolution 2024 ·Journal of Medicinal Chemistry ·(unknown),(unknown),Heinrich Meier,Alexander Straub,Joachim Mittendorf,Jens Schamberger,Martina Schäfer,(unknown),(unknown),(unknown),Katja Zimmermann,Adrian Tersteegen,(unknown),Elke Hartmann,Barbara Albrecht‐Küpper,Pedro D’Orléans-Juste,(unknown),(unknown),Stefan Heitmeier,Hanna Tinel	1
2	BAY-6096: A Potent, Selective, and Highly Water-Soluble Adrenergic α_2B Antagonist 2023 ·Journal of Medicinal Chemistry ·Daniel Meibom,Jutta Meyer,(unknown),Karl D. Collins,(unknown),Kersten M. Gericke,Jörg Hüser,Joachim Mittendorf,(unknown),Jens Schamberger,Jan Stampfuss,Alexander Straub,Afra Torge,(unknown),Frank Wunder	2
3	Potent and Selective Human Neutrophil Elastase Inhibitors with Novel Equatorial Ring Topology: in vivo Efficacy of the Polar Pyrimidopyridazine BAY‐8040 in a Pulmonary Arterial Hypertension Rat Model 2015 ·ChemMedChem ·Franz von Nussbaum,(unknown),Daniel Meibom,(unknown),Martin Bechem,Martina Delbeck,Michael Gerisch,Axel Harrenga,(unknown),Dieter Lang,Klemens Lustig,Joachim Mittendorf,Martina Schäfer,Stefan Schäfer,Jens Schamberger	28
4	The Chemistry and Biology of Soluble Guanylate Cyclase Stimulators and Activators 2013 ·Angewandte Chemie International Edition ·Markus Follmann,Nils Griebenow,Michael G. Hahn,Ingo V. Hartung,(unknown),Joachim Mittendorf,Martina Schäfer,Hartmut Schirok,Johannes‐Peter Stasch,Friederike Stoll,Alexander Straub	159
5	Identification of acidic heterocycle-substituted 1H-pyrazolo[3,4-b]pyridines as soluble guanylate cyclase stimulators 2013 ·Bioorganic & Medicinal Chemistry Letters ·Nils Griebenow,Hartmut Schirok,Joachim Mittendorf,Alexander Straub,Markus Follmann,Johannes‐Peter Stasch,(unknown),Karl‐Heinz Schlemmer,(unknown)	10
6	Discovery of BAY 94‐8862: A Nonsteroidal Antagonist of the Mineralocorticoid Receptor for the Treatment of Cardiorenal Diseases 2012 ·ChemMedChem ·Lars Bärfacker,Alexander Kühl,Alexander Hillisch,Rolf Grosser,Santiago Figueroa‐Pérez,Heike Heckroth,(unknown),Jens‐Kerim Ergüden,Heike Gielen‐Haertwig,Karl‐Heinz Schlemmer,Joachim Mittendorf,Holger Paulsen,Johannes Platzek,Peter Kolkhof	199
7	Discovery of Riociguat (BAY 63‐2521): A Potent, Oral Stimulator of Soluble Guanylate Cyclase for the Treatment of Pulmonary Hypertension 2009 ·ChemMedChem ·Joachim Mittendorf,Stefan Weigand,Cristina Alonso‐Alija,Erwin Bischoff,Achim Feurer,Michael Gerisch,Armin Kern,(unknown),Dieter Lang,(unknown),Martin Radtke,Hartmut Schirok,Karl‐Heinz Schlemmer,Elke Stahl,Alexander Straub,Frank Wunder,Johannes‐Peter Stasch	145
8	Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension 2009 ·BMC Pharmacology ·Joachim Mittendorf,Stefan Weigand,Cristina Alonso‐Alija,Erwin Bischoff,Achim Feurer,Michael Gerisch,Armin Kern,(unknown),Dieter Lang,(unknown),Martin Radtke,Hartmut Schirok,Karl‐Heinz Schlemmer,Elke Stahl,Alexander Straub,Frank Wunder,Johannes‐Peter Stasch	2
9	Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension 2008 ·European Respiratory Journal ·Ralph T. Schermuly,J.-P. Stasch,Soni Savai Pullamsetti,Ralf Middendorff,D. Müller,Klaus‐Dieter Schlüter,(unknown),(unknown),Ewa Kołosionek,(unknown),Rio Dumitrascu,Norbert Weißmann,Joachim Mittendorf,Walter Klepetko,Werner Seeger,Hossein Ardeschir Ghofrani,Friedrich Grimminger	188
10	Design and Synthesis of Potent and Selective Azaindole‐Based Rho Kinase (ROCK) Inhibitors 2008 ·ChemMedChem ·Hartmut Schirok,Raimund Kast,Santiago Figueroa‐Pérez,(unknown),Mark Jean Gnoth,Achim Feurer,Heike Heckroth,(unknown),Holger Paulsen,(unknown),Joachim Hütter,Mario Lobell,Klaus Münter,(unknown),Heimo Ehmke,Dieter Lang,Martin Radtke,Joachim Mittendorf,Johannes‐Peter Stasch	35
11	Cardiovascular effects of a novel potent and highly selective azaindole‐based inhibitor of Rho‐kinase 2007 ·British Journal of Pharmacology ·R. Kast,Hartmut Schirok,Santiago Figueroa‐Pérez,Joachim Mittendorf,Mark Jean Gnoth,Heiner Apeler,(unknown),Jürgen K. Franz,(unknown),Joachim Hütter,Mario Lobell,Katharina Zimmermann,Klaus Münter,(unknown),Heimo Ehmke,J.-P. Stasch	56
12	In Vitro Activity and In Vivo Efficacy of Icofungipen (PLD-118), a Novel Oral Antifungal Agent, against the Pathogenic Yeast Candida albicans 2006 ·Antimicrobial Agents and Chemotherapy ·(unknown),(unknown),(unknown),(unknown),Mihael Skerlev,Joachim Mittendorf,(unknown),Axel Schmidt,(unknown)	33
13	Alicyclic β-amino acids in Medicinal Chemistry 2005 ·Amino Acids ·Alexander Kühl,Michael G. Hahn,Miljenko Dumić,Joachim Mittendorf	109
14	Novel antifungal β-amino acids: synthesis and activity against Candida albicans 2003 ·Bioorganic & Medicinal Chemistry Letters ·Joachim Mittendorf,Franz Kunisch,(unknown),Hans‐Christian Militzer,Axel Schmidt,W. Schönfeld	103
15	Efficient Asymmetric Synthesis of β-Amino Acid BAY 10-8888/PLD-118, a Novel Antifungal for the Treatment of Yeast Infections 2003 ·Synthesis ·Joachim Mittendorf,Jordi Benet‐Buchholz,Peter Fey,(unknown)	34
16	Characterization of the Diarylether Sulfonylester (−)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a Potent Cannabinoid Receptor Agonist with Neuroprotective Properties 2002 ·Journal of Pharmacology and Experimental Therapeutics ·Frank Mauler,Joachim Mittendorf,Ervin Horváth,Jean De Vry	83
17	Substituted uracil derivatives as potent inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1) 2002 ·Bioorganic & Medicinal Chemistry Letters ·Henning Steinhagen,Michael Gerisch,Joachim Mittendorf,Karl‐Heinz Schlemmer,(unknown)	19
18	Contribution to the synthesis of aureobasidin A. Synthesis of cyclopeptolides containing the sequence leucyl‐N‐methyl‐β‐hydroxyvalyl‐ (2R)‐oxy‐(3R)‐methyl‐pentanoic acid * 1998 ·Journal of Peptide Research ·Ulrich Schmidt,Andreas Schumacher,Joachim Mittendorf,Bernd Riedl	6
19	The First Hexabutadiynylbenzenes: Synthesis and Structures 1992 ·Angewandte Chemie International Edition in English ·James R. Green,Joachim Mittendorf,Debra L. Mohler,K. Peter C. Vollhardt,Roland Boese	59
20	Von 2,5‐Dihydropyrazinen zu 2H‐1,4‐Diazepinen und von Benzodihydroarenen zu Benzocyclohepten‐Derivaten, Strukturvarianten des Antidepressivums Protriptylin 1989 ·Angewandte Chemie ·Ulrich Schöllkopf,Joachim Mittendorf	3

About Joachim Mittendorf

Joachim Mittendorf is a scholar working on Physiology, Toxicology and Organic Chemistry, having authored 29 papers that have together received 1.4k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (7 papers), Nitric Oxide and Endothelin Effects (7 papers) and Pulmonary Hypertension Research and Treatments (5 papers). The work is most often cited by research in Organic Chemistry (435 citations), Cardiology and Cardiovascular Medicine (327 citations) and Toxicology (38 citations). Joachim Mittendorf has collaborated with scholars based in Germany, United States and Croatia. Frequent co-authors include Michael G. Hahn, Alexander Kühl, Hartmut Schirok, Johannes‐Peter Stasch, Karl‐Heinz Schlemmer, Miljenko Dumić, Alexander Straub, K. Peter C. Vollhardt, Debra L. Mohler and Roland Boese. Their work appears in journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact